Log in to save to my catalogue

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses th...

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_481913bfae7549a8909dc48c57cf66bb

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells

About this item

Full title

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-01, Vol.11 (1), p.2074-2074, Article 2074

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The novel small molecule PTC596 inhibits microtubule polymerization and its clinical development has been initiated for some solid cancers. We herein investigated the preclinical efficacy of PTC596 alone and in combination with proteasome inhibitors in the treatment of multiple myeloma (MM). PTC596 inhibited the proliferation of MM cell lines as we...

Alternative Titles

Full title

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_481913bfae7549a8909dc48c57cf66bb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_481913bfae7549a8909dc48c57cf66bb

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-81577-x

How to access this item